NCT03694262 The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) Status COMPLETED Phase PHASE2
NCT03682289 Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03675893 RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer Status RECRUITING Phase PHASE2
NCT03667716 COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Status COMPLETED Phase PHASE1
NCT03665285 A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT03629756 A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT03611517 Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer Status UNKNOWN Phase NA
NCT03595722 Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers Status UNKNOWN Phase NA
NCT03572478 Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT03567655 Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer Status UNKNOWN Phase PHASE2
NCT03564340 Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers Status RECRUITING Phase PHASE1/PHASE2
NCT03555422 Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO] Status COMPLETED Phase PHASE3
NCT03543215 Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer? Status RECRUITING Phase N/A
NCT03538665 The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons Status RECRUITING Phase N/A
NCT03526432 Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03503786 Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer Status UNKNOWN Phase PHASE2